January 27, 2022
Life Sciences
  • The Biden administration redirected nearly $7 billion from an emergency relief fund for health care providers in order to buy COVID-19 vaccines and treatments, leaving the emergency fund nearly empty. A spokesperson HHS defended the decision, saying it was a reasonable use of the hospital and clinic funds because the vaccines and therapeutics purchased were given to providers at no cost. The administration also plans to divert another $1 billion that Congress set aside for testing to buy more vaccines and therapeutics. (Article here)